1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow AlgoTherapeutix: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EASE (Efficacy of ATX01 Study in Erythromelalgia) Amitriptyline Hydrochloride, Placebo - Erythromelalgia | Phase 2 | Completed | AlgoTherapeutix | 14 | 2023-06-14 | 2024-04-18 |
| Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) ATX01 10%, ATX01 15%, Placebo - Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Active not recruiting | AlgoTherapeutix | 276 | 2023-02-28 | 2024-07-16 |
Erythromelalgia (1)
Amitriptyline (1)
United States (2) · Belgium (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Spain (1)